Business Context and Reporting Period
Company: Lifecore Biomedical, Inc. (LFCR)
Filing Type: Form 8-K (Current Report)
Report Date: May 6, 2026
Reporting Period: First quarter ended March 31, 2026
This filing announces the issuance of a press release regarding consolidated financial results for the first quarter of 2026 and the availability of investor presentation materials on the company's website.
Key Financial Metrics
The provided text serves as a cover document referencing external exhibits (Exhibit 99.1 and 99.2) for detailed data. The filing text itself does not provide specific values for the following metrics:
- Revenue
- Profit (Net Income/Loss)
- Cash Flow
- Margins
- Debt Levels
- Liquidity Position
Note: Specific financial figures are contained in the referenced Press Release (Exhibit 99.1) and Investor Presentation (Exhibit 99.2), which are not included in the input text.
Material Changes
The filing text does not disclose specific material changes in financial condition or operations compared to prior periods. It only confirms that results for the quarter ended March 31, 2026, have been announced.
Guidance, Outlook, and Risks
Management Commentary: The company has released a press release and investor presentation materials containing management commentary and outlook, but the specific content of these documents is not detailed in the 8-K text provided.
Risks and Contingencies: No specific risks or contingencies are described in the body of this filing. The document includes standard disclaimers stating that the furnished information is not "filed" under Section 18 of the Exchange Act and is not incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific Q1 2026 revenue, earnings, and cash flow figures.
- Examine Exhibit 99.2 (Investor Presentation) for updated guidance, strategic outlook, and operational highlights.
- Verify the company's status as an emerging growth company (indicated as "Not Applicable" in the filing).
- Confirm the trading symbol (LFCR) and exchange (NASDAQ Global Select Market) for accurate market data retrieval.